Wednesday, March 20, 2019

Finnish-Kenyan AIDS drug aims for global market

UCL, a Kenya-based drug manufacturer in Finnfund’s investment portfolio, is one of just a handful of African companies to have a medicine approved by WHO for sale on the global market.

But to win contracts with big buyers like Global Fund, Pepfar or Unicef, UCL must compete against Indian drug manufacturers.

Development Today is a subscription-based online journal. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.